Biomarker or Test Protocol Involved in the Anti-HBV Treatment with HOOIMM plus B:-
1. HBV Serological markers which include HBsAg Elisa.
2. Serum Alanine Aminotransferase (ALT) or Serum glutamic pyruvic transaminase (SGPT) & Aspartate Aminotransferase (AST) or SGOT.
3. HBV Quantification-Viral Load.
4. Hepatitis B surface antibody (anti-HBs)
Note: Quantification of HBV reflects the viral load which plays a critical role in determining the phase of infection, deciding the treatment and determining the response to anti-viral treatment.
The presence of anti-HBs is generally interpreted as indicating recovery and immunity from hepatitis B virus infection. Anti-HBs also develops in a person who has been successfully vaccinated against hepatitis B or successfully treated.